Omron Raises Revenue Forecast to ¥920 Billion and Operating Profit to ¥88 Billion
Key Facts
Omron raised its forecasts for the fiscal year ending March 31, 2027, targeting revenue of ¥920 billion and operating profit of ¥88 billion in a revision announced on November 10 following its first-half results. The company said the new revenue forecast is 4.5% above its previous estimate of ¥880 billion, while its operating profit forecast is up 10% from ¥80 billion. The revision also included an increase in the forecast for profit attributable to owners of the parent, to ¥43 billion from ¥40.5 billion. This followed growth in revenue and earnings during the six months from April 1 to September 30, 2026. The figures reflect improved sales and profitability, with clear differences among business units.
Omron's first-half revenue reached ¥425.264 billion, up 22.9% from ¥345.915 billion in the same period a year earlier. Operating profit climbed 161.5% to ¥40.561 billion, while profit attributable to owners of the parent was ¥27.413 billion, compared with ¥4.637 billion a year earlier. The gross profit margin rose to 47.7% from 45.6%, while the operating margin improved to 9.5% from 4.5%. The results show revenue growth alongside expanding margins, with operating profit rising faster than sales. The company reported results for the period ended September 30 within its fiscal year ending in March 2027.
Industrial automation, which the company calls IAB, was the main driver of growth across its businesses, with first-half revenue rising 36.2%. Omron attributed the unit's performance to semiconductor investment linked to AI demand and to data-center batteries. The company said it aims to benefit from “semiconductor investment driven by AI demand.” Revenue at its HCB healthcare unit also increased 16%, supported by promotions for new blood pressure monitors that helped lift sales globally. The DSB unit recorded revenue growth of 24.5%, completing gains in three of the four units in the first half.
By contrast, revenue at the SSB unit fell 14.4%, highlighting uneven performance across the company’s businesses despite overall growth. Omron said the unit’s sales declined because of weakness in energy-related activity as competition intensified in the domestic battery-storage systems market. It added that mobility and management-services activities remained stable, but this did not prevent an overall drop in unit sales. The company kept its SSB revenue forecast for the fiscal year at ¥148 billion, unchanged from its previous estimate. This stability contrasts with higher forecasts for the industrial automation and healthcare units, while the DSB revenue estimate also remained unchanged.
Omron raised its fiscal-year IAB revenue forecast to ¥540 billion from ¥510 billion and increased its HCB forecast to ¥165 billion from ¥155 billion. By contrast, it kept its SSB revenue forecast at ¥148 billion and DSB at ¥62 billion. It also set its fiscal-year basic earnings-per-share forecast at ¥218.68, alongside the increase in its forecast for profit attributable to owners of the parent. These estimates distribute the impact of the revision unevenly across the units, with the segment increases concentrated in industrial automation and healthcare. DSB’s first-half growth was not accompanied by a change to its annual revenue forecast.
On shareholder returns, the company decided to pay an interim dividend of ¥55 per share, while keeping its full-year dividend forecast at ¥110 per share. The interim dividend decision comes alongside higher fiscal-year earnings estimates, while the annual dividend forecast is unchanged from the original plan. Omron shares, listed under the ticker 6645.t, closed at ¥4,821 on November 9, according to EL7 data. The company said it is scheduled to file its semiannual securities report on November 13, 2026. The dividend is scheduled to be paid on December 2, 2026.